PRVAPrivia Health Group, Inc.
Is the price fair?
The yardsticks disagree: cheap against its own 5-year P/E range (14th percentile) but the cash-flow math implies demanding growth. Treat as fair, not cheap.
Cheap vs its own history: P/E 106.8 vs a 136.6 median over 14 quarters (−22% vs median).
Sector median 25.1× across 135 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What PRVA's price assumes
Privia Health Group, Inc. trades at 107× earnings against 46.9× for the median Health Information Services name, more expensive than its own group.
Trailing P/E · Health Information Services median 46.9 · 2.28× the median: the market pays up for this one
- Price / sales
- 1.21
Price / sales · today's price, trailing year to Jun 30, 2026
- Price / book
- 3.66
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 1.01
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 3.66
- EV / EBIToperating margin 1.9%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 1.01
- Healthcare median P/E503 names
- 27.9
- Health Information Services median P/E24 names
- 46.9
- Market capitalisation127.7 million shares, counted Jul 31, 2026
- $2.86B
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $25.72 |
| Its own P/E history, median | $28.68 |
| Its own P/E history, upper quartile | $38.80 |
| 52-week range | $19.11 – $28.09 |
| Today | $22.42 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Against its own past
Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.
Health Information Services
Ranks #12 of 18 by RyuScore